Business

Mirion to Elevate Radiopharmaceutical Production Quality with Advanced Apex-Guard Software

ATLANTA, April 01, 2025--Mirion Technologies (NYSE: MIR), a global provider of advanced radiation safety solutions, today announced the latest release of its Apex-Guard gamma spectroscopy software. Tailored to meet the stringent regulatory demands of commercial radioisotope producers, Apex-Guard software V1.2 significantly enhances the Mirion solutions suite within the radiopharmaceutical supply chain with a robust impurity analysis for radioisotope producers. This software release reinforces th

articleMirion Technologies, Inc.April 1, 20253/company/mirion-technologies-inc/news/mirion-elevate-radiopharmaceutical-production-quality-200300088
Mirion to Elevate Radiopharmaceutical Production Quality with Advanced Apex-Guard Software

About this update from Mirion Technologies, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2091,"height":617,"url":"https://media.zenfs.com/en/business-wire.com/07f0740cd0d02f0a7266f3368f9e1bcc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/u1ck5ajAYwfkg7wnr4uJeA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI4MztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/07f0740cd0d02f0a7266f3368f9e1bcc","width":960,"height":283},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/1GAf0RWwALn45KGEt5CI4Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03MDg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/07f0740cd0d02f0a7266f3368f9e1bcc","width":1200,"height":354}},"lazy":false},{"type":"text","content":"Apex-Guard™ Software Version 1.2 Introduces Robust Impurity Analysis for Enhanced Radioisotope Quality","length":102,"tagName":"p","attribs":{}},{"type":"text","content":"ATLANTA, April 01, 2025--(BUSINESS WIRE)--Mirion Technologies (NYSE: MIR), a global provider of advanced radiation safety solutions, today announced the latest release of its Apex-Guard gamma spectroscopy software. Tailored to meet the stringent regulatory demands of commercial radioisotope producers, Apex-Guard software V1.2 significantly enhances the Mirion solutions suite within the radiopharmaceutical supply chain with a robust impurity analysis for radioisotope producers. This software release reinforces the Mirion commitment to improving quality in cancer care, through focused innovation across its Mirion Technologies and Mirion Medical groups.","length":658,"tagName":"p"},{"type":"text","content":"The radiopharmaceutical field is experiencing rapid expansion, with over 100 drugs currently in Phase I or further clinical development stages1 poised to revolutionize patient-centric diagnosis and treatment in cancer care and other medical specialties. To manage the growth, radioisotope producers require robust quality management and impurity analysis to ensure compliance and patient safety.","length":395,"tagName":"p"},{"type":"text","content":"Building on the established Mirion Technologies Genie™ and Apex-Gamma™ gamma spectroscopy software platforms, Apex-Guard software offers advanced controls, security, audit features, and data integrity. These features support compliance with regulations such as U.S. FDA 21 CFR Part 112. The...

More updates from Mirion Technologies, Inc.

Mirion TechnologiesApex-Guardlatest releasecancer careradiation safetyradiopharmaceuticalquality managementradioisotope